Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


University of Iowa Interventional Psychiatry Service Patient Registry


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04480918

Organisation Name: University of Iowa

Overal Status: Recruiting

Start Date: November 2, 2020

Last Update: November 3, 2020

Lead Sponsor: Mark Niciu

Brief Summary: The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD). These treatments include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), racemic ketamine infusion and intranasal esketamine insufflation. The investigators will obtain various indicators, or biomarkers, of a depressed individuals' state before, during, and/or after these treatments. Such biomarkers include neurobehavioral testing, neuroimaging, electroencephalography, cognitive testing, vocal recordings, epi/genetic testing, and autonomic nervous system measures (i.e. "fight-or-flight" response). The results obtained from this study may provide novel antidepressant treatment response biomarkers, with the future goal of targeting a given treatment to an individual patient ("personalized medicine").

Conditions:
  • Treatment Resistant Depression
  • Major Depressive Episode
  • Major Depression
  • Major Depressive Disorder
  • Bipolar Disorder
  • Bipolar Depression


Total execution time in seconds: 0.22271299362183